Application of botulinum toxin to clinical therapy: advances and cautions.

  title={Application of botulinum toxin to clinical therapy: advances and cautions.},
  author={Norman S Levy and David T. Lowenthal},
  journal={American journal of therapeutics},
  volume={19 4},
The therapeutic use of botulinum toxin Type A has followed a novel and unanticipated pathway of applications, from its initial application by Scott to paralyze the extraocular muscles of the eyes to correct strabismus. In the late 1970s, Scott formed a company, called Oculinum Inc, to make botulinum toxin Type A available for this ophthalmic application. From this modest and limited beginning, it has found use for treatment of a plethora of cosmetic, neuromuscular, and skeletal disabilities… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS